Ikuko Kishida

960 total citations
33 papers, 636 citations indexed

About

Ikuko Kishida is a scholar working on Psychiatry and Mental health, Cardiology and Cardiovascular Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, Ikuko Kishida has authored 33 papers receiving a total of 636 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Psychiatry and Mental health, 11 papers in Cardiology and Cardiovascular Medicine and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Ikuko Kishida's work include Schizophrenia research and treatment (12 papers), Electroconvulsive Therapy Studies (9 papers) and Heart Rate Variability and Autonomic Control (8 papers). Ikuko Kishida is often cited by papers focused on Schizophrenia research and treatment (12 papers), Electroconvulsive Therapy Studies (9 papers) and Heart Rate Variability and Autonomic Control (8 papers). Ikuko Kishida collaborates with scholars based in Japan, United States and Sweden. Ikuko Kishida's co-authors include Yoshio Hirayasu, Taku Furuno, Chiaki Kawanishi, Daiji Kato, Norio Ishii, Mami Fujibayashi, Toshio Moritani, Hana Hasegawa, Norio Yasui‐Furukori and Akira Suda and has published in prestigious journals such as Neuropsychopharmacology, Molecular Psychiatry and Journal of Affective Disorders.

In The Last Decade

Ikuko Kishida

32 papers receiving 616 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ikuko Kishida Japan 15 282 139 119 78 64 33 636
Bruno Agustini Australia 13 203 0.7× 105 0.8× 104 0.9× 64 0.8× 101 1.6× 23 915
Jonathan G. Leung United States 15 339 1.2× 94 0.7× 78 0.7× 43 0.6× 221 3.5× 92 1.0k
Thomas J. Arndt United States 8 760 2.7× 61 0.4× 147 1.2× 71 0.9× 171 2.7× 8 1.1k
Peter N. van Harten Netherlands 17 436 1.5× 34 0.2× 173 1.5× 29 0.4× 52 0.8× 48 858
J. Caudle United States 13 234 0.8× 77 0.6× 91 0.8× 202 2.6× 37 0.6× 28 698
Erika L. Nurmi United States 16 181 0.6× 26 0.2× 174 1.5× 53 0.7× 56 0.9× 31 748
Bjanka Vuksan‐Ćusa Croatia 17 292 1.0× 34 0.2× 194 1.6× 70 0.9× 68 1.1× 36 694
Cedric O’Gorman United States 13 450 1.6× 56 0.4× 107 0.9× 42 0.5× 82 1.3× 31 609
Fouzia Laghrissi‐Thode United States 12 176 0.6× 445 3.2× 57 0.5× 75 1.0× 172 2.7× 17 855
Chay‐Hoon Tan Singapore 14 270 1.0× 44 0.3× 39 0.3× 22 0.3× 55 0.9× 24 592

Countries citing papers authored by Ikuko Kishida

Since Specialization
Citations

This map shows the geographic impact of Ikuko Kishida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ikuko Kishida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ikuko Kishida more than expected).

Fields of papers citing papers by Ikuko Kishida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ikuko Kishida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ikuko Kishida. The network helps show where Ikuko Kishida may publish in the future.

Co-authorship network of co-authors of Ikuko Kishida

This figure shows the co-authorship network connecting the top 25 collaborators of Ikuko Kishida. A scholar is included among the top collaborators of Ikuko Kishida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ikuko Kishida. Ikuko Kishida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Suda, Akira, Ikuko Kishida, Taku Furuno, et al.. (2023). Differences in autonomic nervous system activity between long-acting injectable aripiprazole and oral aripiprazole in schizophrenia. BMC Psychiatry. 23(1). 135–135. 4 indexed citations
2.
Sakurai, Hitoshi, Masaki Kato, Norio Yasui‐Furukori, et al.. (2020). Pharmacological management of bipolar disorder: Japanese expert consensus. Bipolar Disorders. 22(8). 822–830. 14 indexed citations
3.
4.
Suda, Akira, Ikuko Kishida, Mami Fujibayashi, et al.. (2018). Effects of long-acting injectable antipsychotics versus oral antipsychotics on autonomic nervous system activity in schizophrenic patients. Neuropsychiatric Disease and Treatment. Volume 14. 2361–2366. 5 indexed citations
5.
Suda, Akira, Ikuko Kishida, Mami Fujibayashi, et al.. (2018). Association between dysfunction of autonomic nervous system activity and mortality in schizophrenia. Comprehensive Psychiatry. 86. 119–122. 11 indexed citations
6.
Kishida, Ikuko, Akira Suda, Mami Fujibayashi, et al.. (2017). Effects of four atypical antipsychotics on autonomic nervous system activity in schizophrenia. Schizophrenia Research. 193. 134–138. 23 indexed citations
7.
Kishida, Ikuko, Akira Suda, Mami Fujibayashi, et al.. (2017). Long term effects of smoking cessation in hospitalized schizophrenia patients. BMC Psychiatry. 17(1). 87–87. 12 indexed citations
8.
Kishida, Ikuko, Akira Suda, Mami Fujibayashi, et al.. (2016). Association of the Cholinergic Muscarinic M2 Receptor with Autonomic Nervous System Activity in Patients with Schizophrenia on High-Dose Antipsychotics. Neuropsychobiology. 74(1). 60–67. 7 indexed citations
9.
Iwamoto, Yohko, Chiaki Kawanishi, Ikuko Kishida, et al.. (2012). Dose-dependent effect of antipsychotic drugs on autonomic nervous system activity in schizophrenia. BMC Psychiatry. 12(1). 199–199. 42 indexed citations
10.
Sugawara, Norio, Norio Yasui‐Furukori, Yasushi Sato, et al.. (2011). Comparison of prevalence of metabolic syndrome in hospital and community-based Japanese patients with schizophrenia. Annals of General Psychiatry. 10(1). 21–21. 30 indexed citations
11.
Sugawara, Norio, Norio Yasui‐Furukori, Yasushi Sato, et al.. (2010). Prevalence of metabolic syndrome among patients with schizophrenia in Japan. Schizophrenia Research. 123(2-3). 244–250. 74 indexed citations
12.
Suda, Akira, Chiaki Kawanishi, Ikuko Kishida, et al.. (2009). Dopamine D<sub>2</sub> Receptor Gene Polymorphisms Are Associated with Suicide Attempt in the Japanese Population. Neuropsychobiology. 59(2). 130–134. 28 indexed citations
13.
Heikkinen, Terho, Riikka Rontu, Terho Lehtimäki, et al.. (2009). MAO-A and COMT genotypes as possible regulators of perinatal serotonergic symptoms after in utero exposure to SSRIs. European Neuropsychopharmacology. 19(5). 363–370. 33 indexed citations
14.
Kato, Daiji, Chiaki Kawanishi, Ikuko Kishida, et al.. (2007). Effects of CYP2D6 polymorphisms on neuroleptic malignant syndrome. European Journal of Clinical Pharmacology. 63(11). 991–996. 20 indexed citations
15.
Kawanishi, Chiaki, Hideki Onishi, Daiji Kato, et al.. (2007). Unexpectedly high prevalence of akathisia in cancer patients. Palliative & Supportive Care. 5(4). 351–354. 10 indexed citations
16.
Kawanishi, Chiaki, Tomoki Yamada, Hana Hasegawa, et al.. (2006). Knowledge and attitude towards suicide among medical students in Japan: Preliminary study. Psychiatry and Clinical Neurosciences. 60(5). 558–562. 27 indexed citations
17.
Kobayashi, Akiko, Chiaki Kawanishi, Takehiko Matsumura, et al.. (2006). Quetiapine-induced neuroleptic malignant syndrome in dementia with Lewy bodies: A case report. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 30(6). 1170–1172. 18 indexed citations
18.
Kato, Daiji, Chiaki Kawanishi, Ikuko Kishida, et al.. (2005). CYP2D6 gene deletion allele in patients with neuroleptic malignant syndrome: Preliminary report. Psychiatry and Clinical Neurosciences. 59(4). 504–507. 13 indexed citations
19.
Kishida, Ikuko, Chiaki Kawanishi, Taku Furuno, et al.. (2003). Lack of association in Japanese patients between neuroleptic malignant syndrome and the TaqI A polymorphism of the dopamine D2 receptor gene. Psychiatric Genetics. 13(1). 55–57. 14 indexed citations
20.
Kawanishi, Chiaki, et al.. (2002). A patient with treatment‐resistant schizophrenia and cytochrome P4502D6 gene duplication. Clinical Genetics. 61(2). 152–154. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bruno Agustini Breakdown of academic impact, for papers by Jonathan G. Leung Breakdown of academic impact, for papers by Thomas J. Arndt Breakdown of academic impact, for papers by Peter N. van Harten Breakdown of academic impact, for papers by J. Caudle Breakdown of academic impact, for papers by Erika L. Nurmi Breakdown of academic impact, for papers by Bjanka Vuksan‐Ćusa Breakdown of academic impact, for papers by Cedric O’Gorman Breakdown of academic impact, for papers by Fouzia Laghrissi‐Thode Breakdown of academic impact, for papers by Chay‐Hoon Tan
Rankless by CCL
2026